Quality of Life Office, International Breast Cancer Study Group Coordinating Center, Bern, Switzerland
Karin Ribi
International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA
Weixiu Luo
Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy
Marco Colleoni
Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy/Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden
Per Karlsson
Box Hill and Maroondah Hospitals, Monash University, Victoria, Australia
Jacquie Chirgwin
Luzerner Kantonsspital, Lucerne, Switzerland
Stefan Aebi
CHU Liège, Liège University, Liège, Belgium
Guy Jerusalem
Multidisciplinary Breast Center, University Hospitals, KU Leuven, Leuven, Belgium
Patrick Neven
Division of Medical Oncology B, CRO-Aviano, Aviano, Italy
Vincenzo Di Lauro
Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru
Henry L. Gomez
Breast Center St. Gallen, Swiss Group for Clinical Cancer Research and International Breast Cancer Study Group, Bern, Switzerland
Thomas Ruhstaller
The Tweed Hospital, Tweed Heads, NSW & Griffith University Gold Coast, Southport, Australia
Ehtesham Abdi
Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy
Laura Biganzoli & Angelo Di Leo
Chilean Cooperative Group for Oncologic Research (GOCCHI), Providencia, Santiago, Chile
Bettina Müller
CHR Verviers, Verviers, Belgium
Annelore Barbeaux
CHC Clinique St. Joseph, Liège, Belgium
Marie-Pascale Graas
Bern University Hospital, Inselspital, Bern, Switzerland
Manuela Rabaglio
Peter MacCallum Cancer Center, University of Melbourne, Melbourne and Breast Cancer Trials Australia & New Zealand, University of Newcastle, Newcastle, Australia
Prudence A. Francis
Department of Oncology, Karolinska Institute and University Hospital, Stockholm, Sweden
Theodoros Foukakis
Institute of Oncology of Southern Switzerland, Bellinzona, Geneva University Hospitals, Geneva, Swiss Group for Clinical Cancer Research (SAKK) and International Breast Cancer Study Group, Bern, Switzerland
Olivia Pagani
Division of Medical Oncology, Ospedale Centrale di Bolzano, Bolzano, Italy
Claudio Graiff
Sandton Oncology Centre, Johannesburg, South Africa
Daniel Vorobiof
International Breast Cancer Study Group Coordinating Center, Bern, Switzerland
Rudolf Maibach
International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA, USA
Richard D. Gelber
International Breast Cancer Study Group and IEO, European Institute of Oncology IRCCS, Milan, Italy
Aron Goldhirsch
International Breast Cancer Study Group and University of Sydney, Sydney, Australia
Alan S. Coates
International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Meredith M. Regan
Quality of Life Office, International Breast Cancer Study Group Coordinating Center and Bern University Hospital, Inselspital, Bern, Switzerland
Jürg Bernhard
